PharmaNutra Expands Global Footprint: Signs Distribution Agreement to Launch Products in Morocco
Rabat, The Gulf Observer: Italian pharmaceutical and nutraceutical company PharmaNutra has officially entered the Moroccan market through a new distribution agreement with Alcantara Pharmaceuticals, expanding its international presence to 88 countries.
According to a press release from PharmaNutra, the agreement was signed in September and covers the registration and upcoming launch of three of the company’s flagship products: SiderAL, SiderAL Gocce, and Apportal. These products are expected to be available to Moroccan consumers starting next year.
The expansion into Morocco follows similar agreements in Bahrain and Peru, positioning Morocco among the latest nations to welcome PharmaNutra’s health supplements and medical devices.
Describing Morocco as “one of the leading economies in Africa,” PharmaNutra emphasized the strategic importance of the move in its global growth strategy.
“These are important numbers, achieved in just over ten years of international activity by the Group, making them even more meaningful,” said Carlo Volpi, CEO of PharmaNutra.
The company continues to strengthen its footprint in emerging and developed markets, aligning with its mission to offer innovative nutritional solutions and medical products worldwide.
